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Oral anticoagulation with vitamin K antagonists (VKA) are widely pre-
scribed for the prophylaxis and treatment of many thrombo-embolic disorders.
The management of patients with VKA represents a public health problem
according to higher number of death and hospitalization in relation to bleeding
complications.
Aim of study: To evaluate patients' knowledge about the acenocumarol
treatment, the therapeutic range of International Normalized Ratio (INR), the
bleeding and thrombotic risks and its interactions with other medications and
food.
Material and methods: 139 consecutives patients on long-term acenocu-
marol treatment were included in this single center descriptive study. The
mean age was 58.9±14 (26-86 years) and 50.4% were male. They were inter-
viewed by a fellow using a questionnaire specifically prepared by the authors.
This questionnaire had 10 questions concerned their understanding of the goal
of the oral anticoagulant therapy, knowledge of target INR ratio, frequency of
INR examination, factors influencing INR values e.g. drugs-drugs interactions
(like aspirin therapy) and food. One point was giving for each question
answered correctly.
Results: The mean total knowledge level was 3.9±2.5 (0-10). Percentages
of correct answers (Level test score>6/10) for the questions evaluating know-
ledge about acenocoumarol treatment did not exceed 18%. Only 23 patients
(16.5%) declared knowledge of target INR ratio and only 52 (37.4%) answered
correctly about the bleeding risk. The knowledge of interactions between
acenocoumarol and other medications in particular aspirin was low (28.6%).
The importance of diet was unknown by almost patients (95.5%). Multivariate
analysis showed two independent predictor factors linked with an insufficient
knowledge (Level test score<4/10): age>60 years (OR=4.7; p<0.001) and an
educational level less than elementary school (OR=3.7; p=0.01). 
Conclusions: Level of patients' knowledge about the oral anticoagulant
treatment was very low among our outpatients. So, it seems very appropriate
to develop special anticoagulant clinics in Tunisia.
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